国际口腔医学杂志 ›› 2020, Vol. 47 ›› Issue (1): 115-120.doi: 10.7518/gjkq.2020029

• 综述 • 上一篇    下一篇

黄连素的生物学功能及治疗口腔疾病研究的进展

崔钰嘉,孙建勋(),周学东   

  1. 口腔疾病研究国家重点实验室 国家口腔疾病临床医学研究中心 四川大学华西口腔医院牙体牙髓病科 成都 610041
  • 收稿日期:2019-05-07 修回日期:2019-09-24 出版日期:2020-01-01 发布日期:2020-01-01
  • 通讯作者: 孙建勋
  • 作者简介:崔钰嘉,博士,Email: 1214697348@qq.com
  • 基金资助:
    四川省科技支撑项目(2016RZ0035)

Progress for understanding the effect of berberine in oral diseases

Cui Yujia,Sun Jianxun(),Zhou Xuedong   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Operative Dentistry and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2019-05-07 Revised:2019-09-24 Online:2020-01-01 Published:2020-01-01
  • Contact: Jianxun Sun
  • Supported by:
    This study was supported by Sichuan Science and Technology Pillar Program(2016RZ0035)

摘要:

黄连素(小檗碱)是从黄连、三颗针、黄柏等天然药物中提取的异喹啉类生物碱,具有广泛的药理作用,能够有效地抗惊厥、抗高血压、抗肿瘤、抗抑郁、抗炎、降血脂、降血糖等。近年来,由于其丰富的生物学功能,人们逐渐发掘出黄连素用于治疗口腔疾病的潜力,研究其与龋病、根尖周炎、牙周病、口腔黏膜病、颌面部肿瘤的关系。本文就黄连素的生物学功能和其在口腔领域中的研究进展作一综述,为进一步研究黄连素在治疗口腔疾病的应用提供参考。

关键词: 黄连素, 龋病, 根尖周炎, 牙周炎, 口腔黏膜病, 肿瘤

Abstract:

Berberine is a benzylisoquinoline alkaloid, occurring as one of the main active ingredients in many traditional herbs including coptis, barberry, phellodendron. Several studies have depicted its anticonvulsant, antihypertensive, antidepressant, anti-inflammatory, hypolipidemic, and antidiabetic biological effect. Depending on a rich and varied biological function, the potential of berberine for curing oral diseases has been discovered recently. Researchers focus on the relation of berberine to oral diseases, such as periodontitis, caries, periapical periodontitis, diseases of oral mucosa, oral/maxillofacial. The review pays attention to the biological function of berberine as well as its roles in oral diseases.

Key words: berberine, caries, periapical periodontitis, periodontitis, diseases of oral mucosa, tumor

中图分类号: 

  • R78
[1] Birdsall TC, Kelly GS . Berberine: therapeutic po-tential of an alkaloid found in several medicinal plants[J]. Alt Med Rev, 1997,2(2):94-103.
[2] 曹鹏, 张紫薇, 李滢 , 等. 异喹啉类生物碱抑菌活性及抑菌机制研究进展[J]. 中国中药杂志, 2016,41(14):2600-2606.
Cao P, Zhang ZW, Li Y , et al. Progress of antibacterial activity and antibacterial mechanism of isoquinoline alkaloids[J]. China J Chin Mater Med, 2016,41(14):2600-2606.
[3] Gao WW, Gopala L, Bheemanaboina RRY , et al. Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter bau-manii[J]. Eur J Med Chem, 2018,146:15-37.
[4] Bang S, Kwon H, Hwang HS , et al. 9-O-butyl-13-(4-isopropylbenzyl) berberine, KR-72, is a potent an-tifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene expression[J]. PLoS One, 2014,9(10):e109863.
[5] Li H, Li XL, Zhang M , et al. Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity[J]. Scand J Im-munol, 2014,79(1):12-19.
[6] Wang X, He X, Zhang CF , et al. Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthri-tis in rats[J]. Biomed Pharmacother, 2017,89:887-893.
[7] Kawano M, Takagi R, Kaneko A , et al. Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by sup-pressing innate and adaptive immune responses[J]. J Neuroimmunol, 2015,289:43-55.
[8] Chitra P, Saiprasad G, Manikandan R , et al. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF- β activation: a biphasic experimental study[J]. Toxicol Lett, 2013,219(2):178-193.
[9] Zou K, Li Z, Zhang Y , et al. Advances in the study of berberine and its derivatives: a focus on antiinflam-matory and anti-tumor effects in the digestive system[J]. Acta Pharmacol Sin, 2017,38(2):157-167.
[10] Liu D, Meng X, Wu DL , et al. A natural isoquinoline alkaloid with antitumor activity: studies of the bio-logical activities of berberine[J]. Front Pharmacol, 2019,10:9.
[11] Mantena SK, Sharma SD, Katiyar SK . Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells[J]. Mol Cancer Ther, 2006,5(2):296-308.
[12] Yan KQ, Zhang C, Feng JB , et al. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells[J]. Eur J Pharmacol, 2011,661(1/ 2/3):1-7.
[13] James MA, Fu HJ, Liu Y , et al. Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis[J]. Mol Carcinog, 2011,50(1):1-7.
[14] Kim S, Han J, Lee SK , et al. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells[J]. J Surg Res, 2012,176(1):e21-e29.
[15] Xu DH, Yang W, Zhou CH , et al. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats[J]. Planta Med, 2010,76(16):1809-1813.
[16] Hu JP, Nishishita K, Sakai E , et al. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt path-ways[J]. Eur J Pharmacol, 2008,580(1/2):70-79.
[17] Zhou XX, Zhang C, Wang XQ , et al. Berberine inhi-bits lipopolysaccharide- and polyethylene particle-induced mouse calvarial osteolysis in vivo[J]. J Surg Res, 2012,173(2):e47-e52.
[18] Lee HW, Suh JH, Kim HN , et al. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK[J]. J Bone Miner Res, 2008,23(8):1227-1237.
[19] Tao K, Xiao DM, Weng J , et al. Berberine promotes bone marrow-derived mesenchymal stem cells osteo-genic differentiation via canonical Wnt/β-catenin signaling pathway[J]. Toxicol Lett, 2016,240(1):68-80.
[20] Holick MF, Lamb JJ, Lerman RH , et al. Hop rho iso- alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial[J]. J Bone Miner Metab, 2010,28(3):342-350.
[21] Singh N, Sharma B . Toxicological effects of ber-berine and sanguinarine[J]. Front Mol Biosci, 2018,5:21.
[22] Marin-Neto JA, Maciel BC, Secches AL , et al. Cardiovascular effects of berberine in patients with severe congestive heart failure[J]. Clin Cardiol, 1988,11(4):253-260.
[23] Yin J, Xing HL, Ye JP . Efficacy of berberine in patients with type 2 diabetes mellitus[J]. Metab Clin Exp, 2008,57(5):712-717.
[24] Yao ZM, Zhang L, Ji G . Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes[J]. J Integr Med, 2014,12(3):135-146.
[25] Li M, Dang YQ, Li Q , et al. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice[J]. Sci Rep, 2019,9(1):8003.
[26] Kulkarni SK, Dhir A . On the mechanism of antide-pressant-like action of berberine chloride[J]. Eur J Pharmacol, 2008,589(1/2/3):163-172.
[27] Simões Pires EN, Frozza RL, Hoppe JB , et al. Ber-berine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved[J]. Brain Res, 2014,1557:26-33.
[28] 王少虎, 樊明文, 边专 . 中草药抗致龋菌的实验研究[J]. 中华口腔医学杂志, 2001,36(5):385-387.
Wang SH, Fan MW, Bian Z . Experimental study of bacteriostatic activity of Chinese herbal medicines on primary cariogenic bacteria in vitro[J]. Chin J Stomatol, 2001,36(5):385-387.
[29] Dziedzic A, Wojtyczka RD, Kubina R . Inhibition of oral streptococci growth induced by the complementary action of berberine chloride and antibacterial compounds[J]. Molecules, 2015,20(8):13705-13724.
[30] 苏瑞云, 任雷 . 黄连提取液对乳牙感染根管消毒作用的研究[J]. 中华口腔医学杂志, 1992,27(5):302-305, T017.
Su RY, Ren L . Study on the effect of Rhizoma Coptidis extract on root canal disinfection of deciduous teeth with infection[J]. Chin J Stomatol, 1992,27(5):302-305, T017.
[31] Xie Q, Johnson BR, Wenckus CS , et al. Efficacy of berberine, an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model[J]. J Endod, 2012,38(8):1114-1117.
[32] Kassebaum NJ, Bernabé E, Dahiya M , et al. Global burden of severe periodontitis in 1990-2010: a syste-matic review and Meta-regression[J]. J Dent Res, 2014,93(11):1045-1053.
[33] 吴益华, 姜广水, 张世周 , 等. 黄连水提取物药膜辅助治疗慢性牙周炎的疗效评价[J]. 上海口腔医学, 2004,13(4):252-255.
Wu YH, Jiang GS, Zhang SZ , et al. The clinical study on the adjunctive effects of aqueous extract from Coptis root for the treatment of chronic periodontitis[J]. Shanghai J Stomatol, 2004,13(4):252-255.
[34] Hu JP, Takahashi N, Yamada T . Coptidis rhizoma inhibits growth and proteases of oral bacteria[J]. Oral Dis, 2000,6(5):297-302.
[35] Jia X, Jia L, Mo L , et al. Berberine ameliorates per-iodontal bone loss by regulating gut microbiota[J]. J Dent Res, 2019,98(1):107-116.
[36] 孙俊毅, 朱春晖, 刘瑾 , 等. 盐酸小檗碱调节大鼠实验性牙周炎牙龈组织MMPs/TIMP 表达变化及其机制[J]. 西安交通大学学报(医学版), 2016,37(4):551-555.
Sun JY, Zhu CH, Liu J , et al. Berberine regulates MMPs/TIMP via inhibition of P38 MAPK/NF-κB phosphorylation and anti-inflammation in rat experi-mental periodontitis[J]. J Xi’an Jiaotong Univ (Med Sci), 2016,37(4):551-555.
[37] 张帆, 余占海 . 盐酸小檗碱对人牙周膜细胞分泌单核细胞趋化蛋白1影响的体外实验[J]. 中华口腔医学杂志, 2012,47(10):610-613.
Zhang F, Yu ZH . Effect of berberine hydrochloride on the secretion of monocyte chemoattractant protein-1 from human periodontal ligament cells in vitro[J]. Chin J Stomatol, 2012,47(10):610-613.
[38] 赵玮, 高承志 . 4种药物对大鼠牙周炎相关细胞因子影响的比较研究[J]. 实用口腔医学杂志, 2010,26(1):47-50.
Zhao W, Gao CZ . A comparative study of the effects of four kinds of drugs on periodontitis-related cyto-kines of rats[J]. J Pract Stomatol, 2010,26(1):47-50.
[39] Zhang R, Yang J, Wu J , et al. Berberine promotes osteogenic differentiation of mesenchymal stem cells with therapeutic potential in periodontal regeneration[J]. Eur J Pharmacol, 2019,851:144-150.
[40] Sun HL, Wu YR, Song FF , et al. Role of PCSK9 in the development of mouse periodontitis before and after treatment: a double-edged sword[J]. J Infect Dis, 2018,217(4):667-680.
[41] Sorsa T, Tjäderhane L, Konttinen YT , et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation[J]. Ann Med, 2006,38(5):306-321.
[42] Tu HP, Fu MM, Kuo PJ , et al. Berberine’s effect on periodontal tissue degradation by matrix metalloproteinases: an in vitro and in vivo experiment[J]. Phyto-medicine, 2013,20(13):1203-1210.
[43] Jiang XW, Zhang Y, Zhu YL , et al. Effects of ber-berine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013,115(2):212-217.
[44] 万韬, 刘国素 . 盐酸小檗碱对口腔黏膜成纤维细胞分化的影响[J]. 细胞与分子免疫学杂志, 2011,27(4):440-441.
Wan T, Liu GS . Effect of berberine on the differentiation of oral fibroblasts[J]. Chin J Cell Mol Immunol, 2011,27(4):440-441.
[45] Kim JS, Oh D, Yim MJ , et al. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells[J]. Oncol Rep, 2015,33(4):1775-1782.
[46] Ho YT, Yang JS, Li TC , et al. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, U-PA and MMP-2 and-9[J]. Cancer Lett, 2009,279(2):155-162.
[1] 和子慕, 李风兰. 数字化口腔定位支架在头颈部肿瘤放射治疗中的应用现状[J]. 国际口腔医学杂志, 2024, 51(1): 28-35.
[2] 傅豫, 何薇, 黄兰. 铁死亡在口腔疾病中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 36-44.
[3] 罗晓洁,王德续,陈晓涛. 基于生物信息学分析铁死亡调控基因与牙周炎的关系[J]. 国际口腔医学杂志, 2023, 50(6): 661-668.
[4] 黄元鸿,彭显,周学东. 骨碎补在治疗口腔骨相关疾病的研究进展[J]. 国际口腔医学杂志, 2023, 50(6): 679-685.
[5] 吴佳敏,夏斌,杨禾丰,许彪. 癌相关成纤维细胞在口腔鳞状细胞癌微环境中作用的研究进展[J]. 国际口腔医学杂志, 2023, 50(6): 711-717.
[6] 龚美灵,程兴群,吴红崑. 牙周炎与帕金森病相关性的研究进展[J]. 国际口腔医学杂志, 2023, 50(5): 587-593.
[7] 徐智博,孟秀萍. 粪肠球菌逃逸宿主免疫防御机制的研究进展[J]. 国际口腔医学杂志, 2023, 50(5): 613-617.
[8] 赵玲帆, 周杨, 叶鑫鑫, 张强. 肾移植术后腮腺低分化黏液表皮样癌1例[J]. 国际口腔医学杂志, 2023, 50(4): 419-422.
[9] 张超颖,李怡宁,龚佳幸,王慧明. 2022年世界卫生组织指南头颈部肿瘤分类的解读:牙源性和颌面部骨肿瘤[J]. 国际口腔医学杂志, 2023, 50(3): 263-271.
[10] 盛南宁,王珏,南欣荣. 性别决定基因盒9在口腔鳞状细胞癌作用机制和治疗中的研究进展[J]. 国际口腔医学杂志, 2023, 50(3): 314-320.
[11] 孙佳,韩烨,侯建霞. 白细胞介素-6-铁调素信号轴调控牙周炎相关性贫血致病机制的研究进展[J]. 国际口腔医学杂志, 2023, 50(3): 329-334.
[12] 高若凡,夏斌. 基于慢性疾病管理理念的重度低龄儿童龋管理方法[J]. 国际口腔医学杂志, 2023, 50(3): 341-346.
[13] 李春洁, 毕小琴, 朱桂全. 口腔颌面部肿瘤患者游离皮瓣修复术的并发症预防及处理[J]. 国际口腔医学杂志, 2023, 50(2): 127-137.
[14] 梁芷瑩,赵苑汐,朱嘉妮,苏勤. 288例前牙显微根尖手术临床资料的回顾性分析[J]. 国际口腔医学杂志, 2023, 50(2): 166-171.
[15] 李潭,梁新华. 盘状蛋白结构域受体1在调控恶性肿瘤进展和治疗中的作用[J]. 国际口腔医学杂志, 2023, 50(2): 230-236.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张新春. 桩冠修复与无髓牙的保护[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 王昆润. 长期单侧鼻呼吸对头颅发育有不利影响[J]. 国际口腔医学杂志, 1999, 26(05): .
[3] 彭国光. 颈淋巴清扫术中颈交感神经干的解剖变异[J]. 国际口腔医学杂志, 1999, 26(05): .
[4] 杨凯. 淋巴化疗的药物运载系统及其应用现状[J]. 国际口腔医学杂志, 1999, 26(05): .
[5] 康非吾. 种植义齿下部结构生物力学研究进展[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 柴枫. 可摘局部义齿用Co-Cr合金的激光焊接[J]. 国际口腔医学杂志, 1999, 26(04): .
[7] 孟姝,吴亚菲,杨禾. 伴放线放线杆菌产生的细胞致死膨胀毒素及其与牙周病的关系[J]. 国际口腔医学杂志, 2005, 32(06): 458 -460 .
[8] 费晓露,丁一,徐屹. 牙周可疑致病菌对口腔黏膜上皮的粘附和侵入[J]. 国际口腔医学杂志, 2005, 32(06): 452 -454 .
[9] 赵兴福,黄晓晶. 变形链球菌蛋白组学研究进展[J]. 国际口腔医学杂志, 2008, 35(S1): .
[10] 庞莉苹,姚江武. 抛光和上釉对陶瓷表面粗糙度、挠曲强度及磨损性能的影响[J]. 国际口腔医学杂志, 2008, 35(S1): .